Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
Details for Australian Patent Application No. 2005286717 (hide)
International Classifications
Event Publications
10 May 2007 PCT application entered the National Phase
PCT publication WO2006/034418 Priority application(s): WO2006/034418
19 July 2007 Change of Name(s) of Applicant(s), Section 104
Robarge, Michael Joseph; Gleason, Elizabeth Ann; Bennani, Youssef L.; Tumey, Lawrence N.; Athersys, Inc. The name of the applicant has been changed to Athersys, Inc.
3 April 2008 Assignment before Grant
Athersys, Inc. The application has been assigned to Wyeth
27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005286718-Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
2005286716-Trivalent metal mediated homogeneous luminescent proximity assay
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser